Trammell Crow is doubling down on its bet on the national biotech market with the $65 million purchase of a Silicon Valley site slated for a research and development project.

Trammell Crow is doubling down on its bet on the national biotech market with the $65 million purchase of a Silicon Valley site slated for a research and development project.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
250 Twin Dolphin Dr, Redwood City, CA
220 Twin Dolphin Dr, Redwood City, CA